Prothena to Present a Broad Range of Scientific and Health Outcomes Data at the 16th International Symposium on Amyloidosis

DUBLIN, Ireland, March 12, 2018 (GLOBE NEWSWIRE) — Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan categories, today announced that it will present new research in both AL and ATTR amyloidosis at the 16th […] Lire la suite »

BioXcel Therapeutics Announces Closing of Initial Public Offering

BRANFORD, Conn., March 12, 2018 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology, today announced the closing of its initial public offering of 5,454,545 shares of common stock at […] Lire la suite »

Zoom Expands Zoom Rooms with New Ecosystem and Integrator Programs

SAN JOSE, Calif., March 12, 2018 (GLOBE NEWSWIRE) — Zoom Video Communications today announced the development of two new programs that will expand the reach and impact of its software-based conference room solution, Zoom Rooms. The company will showcase the scope of its Technology Ecosystem Program and Certified Integrator Program, […] Lire la suite »

SD-WAN Market Leader Aryaka Unveils PASSPORT: Multi-Layered Security Platform and Ecosystem, Partners with Palo Alto Networks, Zscaler, and Radware

SAN MATEO, Calif., March 12, 2018 (GLOBE NEWSWIRE) — Aryaka®, the leading global SD-WAN provider, today unveiled PASSPORT, its multi-layered security platform and ecosystem, providing global enterprises with best-in-class application performance and security. “In today’s cloud-centric world, global organizations are looking to SD-WAN to deliver solutions that offer reliable global […] Lire la suite »